As the number of people living with congenital heart disease climbs and most patients in poorer regions go without timely care, a Toronto-based AI imaging company is joining a new global alliance built to close that gap. TORONTO, ON, June 16, 2026  — Equity Insider — News Commentary — Congenital heart disease is the most common […]

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that is where one Nasdaq-listed company has placed its bet. NEW YORK, June 16, 2026  — Equity Insider News Commentary — The story […]